In total 12,318 women were diagnosed with screen-related breast cancer and included in this study, of which luminal was the most commonly diagnosed breast cancer and accounted for 70.9% of the total diagnosed breast cancers followed by luminal-HER2-positive, TNBC, and HER2-positive breast cancers at 11.3%, 4.7%, and 1.8%, respectively (Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.